Group 1: Regulatory Actions - The National Internet Information Office and the China Securities Regulatory Commission have taken action to address false information related to the capital market, targeting accounts that spread rumors and illegally recommend stocks [1] Group 2: Market Developments - The Shenzhen Stock Exchange and China Securities Depository and Clearing Corporation have issued a notice to support foreign institutional investors in conducting bond repurchase transactions, effective immediately [2] - The foreign exchange market in China has maintained stability, with a surplus of $15.7 billion in November, consistent with October levels [3] Group 3: Company News - China Shenhua plans to acquire 100% equity stakes in several subsidiaries of the State Energy Group for a total transaction price of 133.598 billion yuan [7] - Nanjing Commercial Travel has terminated its major asset restructuring plan and withdrawn its application, stating that this will not significantly impact its business or financial status [6] - Tianpu Co. announced a public tender offer for 33.52 million shares, representing 25% of its total share capital, at a price of 23.98 yuan per share [5] - Dongfang Zhizao's controlling shareholder is undergoing a change, with a share transfer agreement signed for 14.33% of the company's total shares [8] - Jinggong Technology plans to invest 426 million yuan in a new intelligent manufacturing base in Wuhan, which will enhance its production capabilities [9] - Bohai Chemical has decided to terminate its major asset restructuring plan due to a lack of agreement on key terms [10]

Group 1 - Sichuan Chengyu's wholly-owned subsidiary plans to acquire 85% equity of Hubei Jingyi Company for 2.409 billion yuan, enhancing the company's control over highway projects [1] - Huadian Technology signed contracts worth approximately 815 million yuan with Huadian Technology Group for a wind power hydrogen production project [2] - Dongfang Cable and its subsidiary won projects totaling approximately 3.125 billion yuan, accounting for 34.37% of the company's audited revenue for 2024 [3] Group 2 - Heng Rui Medicine received approval for clinical trials of SHR-2906 injection, a self-developed biopharmaceutical aimed at weight control and metabolic regulation [4] - Qingdao Port plans to invest approximately 15.7 billion yuan in two terminal projects [5] - Jingu Co. received a notification to supply low-carbon wheels for two export models to a major domestic car manufacturer, with production expected in 2026 [6] Group 3 - ST Xingguang won a procurement project worth approximately 22.955 million yuan, accounting for 11.96% of the company's revenue for 2024 [7] - Xinbo Co. plans to jointly invest in an alloy materials research institute with partners, focusing on high-performance materials for various industries [8] - Tianqi Lithium's third-phase lithium concentrate expansion project has been completed and is undergoing trial production, with a total capacity of 2.14 million tons per year [9] Group 4 - Changfei Fiber reported that new fiber optic products related to data centers represent a small proportion of total demand [10] - Dongfang Bio's subsidiaries obtained multiple medical device registration certificates, including various testing kits [11] - Xiugang Co. plans to use up to 500 million yuan of idle fundraising for cash management in safe, liquid investment products [12] Group 5 - Jifeng Co. received a project designation for passenger car seat assemblies from a European luxury brand, with a total lifecycle value of approximately 9.8 billion yuan [13] - CanSino initiated Phase I clinical trials for a combined vaccine, completing the first subject enrollment [14] - Dayu Water-saving's subsidiary pre-won a drainage project worth 140 million yuan and another project worth 1 billion yuan [15] Group 6 - Yutong Pharmaceutical's subsidiary received clinical trial approval for YKYY032 injection for treating hyperlipoproteinemia [17] - Diweier announced the departure of a core technical personnel, impacting its technical leadership [18] - Weilang Co.'s controlling shareholder received regulatory measures from the Shandong Securities Regulatory Bureau for failing to fulfill a commitment [19] Group 7 - Xiehe Electronics invested 5 million yuan in a private equity fund focusing on hard technology sectors [20] - Phoenix Optical received a government subsidy of 4.7053 million yuan, representing 35% of its projected net profit for 2024 [21] - China State Construction reported a 0.9% year-on-year increase in new contracts signed in the first 11 months of 2025, totaling 4.0408 trillion yuan [22] Group 8 - Nanguang Energy's pumped storage power station units 1 and 2 have entered trial operation, with units 3 and 4 expected to follow by year-end [23] - Jindalai plans to invest 280 million yuan to acquire a 34% stake in Yunnan Jici Medical Technology [24] - Geer Software terminated its planned acquisition of a majority stake in Weipin Zhiyuan due to failure to reach agreement on key terms [25] Group 9 - Ningbo Fubang completed the absorption merger of its wholly-owned subsidiary, inheriting all assets and liabilities [26] - Zhongyuan Neipei signed a strategic cooperation framework agreement with Ningbo Puzhi Company for humanoid robot-related business [28] - Gongyuan Co. announced a business integration and relocation of its production lines in the East China region [29] Group 10 - Chlor-alkali Chemical's subsidiary plans to invest 2.975 billion yuan in a comprehensive utilization project for waste salt [30] - Kain Technology announced the departure of a core technical personnel, impacting its research capabilities [31] - ST Renfu received approval for clinical trials of a new drug for idiopathic pulmonary fibrosis [32] Group 11 - Sanbo Brain Science's established brain science fund has completed registration with the Asset Management Association of China [33] - Tongyou Technology plans to apply for a 70 million yuan credit line from Beijing Bank, using its property as collateral [34] - Bai Ao Intelligent signed a significant equipment sales contract worth approximately 27.5021 million yuan [35] Group 12 - ST Xinyan received all restructuring investment funds totaling 2.239 billion yuan, entering the execution phase of its restructuring plan [36] - Dalu Real Estate's subsidiary decided to terminate a planned acquisition of a 60% stake in Beijing Chengzhu Real Estate [38] - Huiyu Pharmaceutical's products received marketing approval in Italy and Norway [39]

继峰股份(603997)12月19日公告，公司的控股子公司Grammer Jifeng Automotive Seating GmbH（简称"格 拉默继峰（德国）"）于近期收到了客户的《定点信》，格拉默继峰（德国）获得了某欧洲豪华品牌主 机厂的乘用车座椅总成项目定点，将为客户开发、生产前中后三排座椅总成产品。 据了解，继峰股份是一家专业从事汽车内饰件及其系统，乘用车座椅以及道路车辆、非道路车辆悬挂驾 驶座椅和乘客座椅的开发、生产和销售的全球性汽车零部件供应商。公司建立了覆盖全球的生产和营销 网络，在全球20个国家拥有超过80家控股子公司。公司持续在座舱内饰件领域做深做强，不断加强自身 的专业能力，构建有竞争力的技术储备和国际运营能力，并结合汽车行业电动化、智能化的快速发展及 驾驶者和乘客对于座舱舒适度需求的提升，积极升级和扩展车内功能，拓展业务中远期发展空间，为提 升座舱内部的舒适性体验提供核心价值。 根据客户规划，该项目为全球销售车型，预计从2028年9月开始，项目生命周期8.5年，生命周期总金额 预计为98亿元。 继峰股份表示，获取 BMW AG（简称"德国宝马"）乘用车座椅总成项目定点的基础上， 公司在 ...

证券代码：603997 证券简称：继峰股份 公告编号：2025-089 项目预计自 2028 年 9 月开始，不会对公司本年度业绩产生重大影响。 宁波继峰汽车零部件股份有限公司 关于获得乘用车座椅总成项目定点的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 宁波继峰汽车零部件股份有限公司（以下简称"公司"）的控股子公司 Grammer Jifeng Automotive Seating GmbH（以下简称"格拉默继峰（德国）"）于 近期收到了客户的《定点信》，格拉默继峰（德国）获得了某欧洲豪华品牌主机 厂（限于保密协议，无法披露其名称，以下简称"客户"）的乘用车座椅总成项 目定点，将为客户开发、生产前中后三排座椅总成产品。 2、公司再次获得海外高端座椅订单，意味着公司海外豪华汽车品牌客户又 增加了一个，标志着公司逐步由国内乘用车座椅供应商向全球乘用车座椅转型， 这将有助于公司进一步拓展海外市场，获得更多海外乘用车座椅订单，也为公司 将来在欧洲地区的生产形成规模经济创造了良好的条件。 《定点信》是客户对格拉 ...

继峰股份（603997）(603997.SZ)公告，公司控股子公司格拉默继峰(德国)于近期收到了客户的《定点 信》，格拉默继峰(德国)获得了某欧洲豪华品牌主机厂的乘用车座椅总成项目定点，将为客户开发、生 产前中后三排座椅总成产品。根据客户规划，本项目为全球销售车型，预计从2028年9月开始，项目生 命周期8.5年，生命周期总金额预计为98亿元。 ...

格隆汇12月19日丨继峰股份(603997.SH)公布,公司控股子公司格拉默继峰(德国)于近期收到客户的《定 点信》，格拉默继峰(德国)获得了某欧洲豪华品牌主机厂的乘用车座椅总成项目定点，将为客户开发、 生产前中后三排座椅总成产品。 公司再次获得海外高端座椅订单，意味着公司海外豪华汽车品牌客户又增加了一个，标志着公司逐步由 国内乘用车座椅供应商向全球乘用车座椅转型，这将有助于公司进一步拓展海外市场，获得更多海外乘 用车座椅订单，也为公司将来在欧洲地区的生产形成规模经济创造了良好的条件。 根据客户规划，本项目为全球销售车型，预计从2028年9月开始，项目生命周期8.5年，生命周期总金额 预计为98亿元。 在获取 BMW AG(简称"德国宝马")乘用车座椅总成项目定点的基础上，公司在海外又获得一家豪华汽车 品牌客户的项目定点，彰显了海外豪华品牌主机厂对公司在乘用车座椅产品开发设计、技术质量、生产 保障能力的认可。 ...

智通财经APP讯，继峰股份(603997.SZ)公告，公司控股子公司格拉默继峰(德国)于近期收到了客户的 《定点信》，格拉默继峰(德国)获得了某欧洲豪华品牌主机厂的乘用车座椅总成项目定点，将为客户开 发、生产前中后三排座椅总成产品。根据客户规划，本项目为全球销售车型，预计从2028年9月开始， 项目生命周期8.5年，生命周期总金额预计为98亿元。 ...

人民财讯12月19日电，继峰股份（603997）12月19日公告，公司的控股子公司Grammer Jifeng Automotive Seating GmbH(简称"格拉默继峰(德国)")于近期收到了客户的《定点信》，格拉默继峰(德国) 获得了某欧洲豪华品牌主机厂的乘用车座椅总成项目定点，将为客户开发、生产前中后三排座椅总成产 品。根据客户规划，该项目为全球销售车型，预计从2028年9月开始，项目生命周期8.5年，生命周期总 金额预计为98亿元。 ...

Core Viewpoint - The company has received a significant project from a European luxury automotive brand, which is expected to positively impact future revenue and operational performance, despite not affecting the current year's results [1] Group 1: Project Details - The company's subsidiary, Grammer Jifeng (Germany), has been awarded a project to develop and produce complete seat assemblies for passenger cars [1] - The project is set to commence in September 2028, with a total lifecycle value estimated at 9.8 billion yuan [1] Group 2: Financial Impact - The project is not expected to have a major impact on the company's performance for the current fiscal year [1] - However, it is anticipated to contribute positively to the company's revenue in future years and have a profound impact on operational performance [1]

继峰股份公告，公司控股子公司格拉默继峰（德国）于近期收到客户的《定点信》，格拉默继峰（德 国）获得了某欧洲豪华品牌主机厂的乘用车座椅总成项目定点，将为客户开发、生产前中后三排座椅总 成产品。根据客户规划，本项目为全球销售车型，预计从2028年9月开始，项目生命周期8.5年，生命周 期总金额预计为98亿元。项目预计自2028年9月开始，不会对公司本年度业绩产生重大影响。 （文章来源：第一财经） ...